Asymptomatic carotid artery stenosis.

Area of Science:

• Vascular Surgery
• Neurology
• Preventive Cardiology

Background:

• Severe asymptomatic carotid stenosis poses a significant annual stroke risk (approx. 2%).
• Effective management involves aggressive risk factor control, including smoking cessation, and treating hypertension, diabetes, and hypercholesterolemia.
• Antiplatelet agents are recommended for all patients with this condition.

Purpose of the Study:

• To evaluate the efficacy of carotid endarterectomy (CEA) for asymptomatic severe carotid stenosis.
• To compare CEA with medical management and other interventions.
• To provide guidance on the optimal management strategy for asymptomatic carotid stenosis.

Main Methods:

• Review of clinical trial data and guidelines regarding asymptomatic carotid stenosis.
• Analysis of stroke risk reduction associated with medical management and surgical intervention (CEA).
• Assessment of patient subgroups (sex, age) benefiting from CEA.

Main Results:

• Carotid endarterectomy (CEA) for stenosis >= 60% reduces annual stroke risk by approx. 1%.
• The benefits of CEA are more pronounced in men and younger individuals.
• Carotid angioplasty and stenting is not recommended over CEA without further clinical trial evidence.
• No evidence supports routine carotid revascularization before other major surgeries like coronary bypass.

Conclusions:

• Aggressive medical management of risk factors is paramount for patients with severe asymptomatic carotid stenosis.
• Carotid endarterectomy (CEA) offers a significant stroke risk reduction for specific patient groups (men, younger patients) with >= 60% stenosis.
• Current evidence does not support carotid angioplasty and stenting as a primary alternative to CEA or routine revascularization before other surgeries.